Lv0
0 积分 2022-06-06 加入
Phased Variant–Supported Circulating Tumor DNA as a Prognostic Biomarker After First-Line Treatment in Large B-Cell Lymphoma: Findings From the DIRECT Study
21天前
已完结
Epcoritamab monotherapy or epcoritamab with lenalidomide as first-line therapy for patients with diffuse large B-cell lymphoma (EPCORE DLBCL-3): primary analysis of an open-label, multicentre, randomised, phase 2 trial
22天前
已完结
CNS prophylaxis for diffuse large B-cell lymphoma
3个月前
已完结
Diffuse Large B-Cell Lymphoma
10个月前
已完结
Ibrutinib in Combination with R-GemOx in Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma of Nongerminal Center B-cell–like Type: Phase II Clinical Trial of the Spanish GELTAMO Group
11个月前
已完结
皖公网安备34019202002308
